EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update.


Journal

HemaSphere
ISSN: 2572-9241
Titre abrégé: Hemasphere
Pays: United States
ID NLM: 101740619

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 07 11 2018
accepted: 11 03 2019
entrez: 15 11 2019
pubmed: 15 11 2019
medline: 15 11 2019
Statut: epublish

Résumé

The inherited disorders of hemoglobin, which include sickle cell disease and thalassemias, are the most common and widespread distributed monogenic disorders. Due to a selective advantage in malaria regions, these hemoglobin defects are particularly frequent in Africa, Asia, or in the Mediterranean areas, where malaria was endemic until the last century. In recent decades, the globalization of migration has contributed to generate multiethnic European societies. Due to migration from countries or regions with high hemoglobinopathy frequencies such as Africa, Middle East, or Asia, large numbers of patients with these disorders are living in almost every European country today. Furthermore, the numbers are increasing because of increasing refugee flows toward Europe. Additional requirements are the development of European recommendations and guidelines for diagnosis and effective therapeutic approaches. These, together with the advancement of clinical trials using new drugs and therapeutic procedures could ameliorate the quality of life of patients affected with these diseases and increase their life expectancy. Lastly, coordinated efforts should be made to develop diagnostic pathways for thalassemias and hemoglobinopathies, in order to plan interventions, including prenatal diagnosis and cure. For these reasons, the development of new tools to reliably diagnose anemias is urgently needed and fits well with the needs of personalized medicine. In the last 15 years, hematology research has made many big leaps forward. Our general aim will be to solve several hematologic problems using these new approaches. We expect that the development of such a diagnostic tool will improve timely diagnosis throughout Europe, especially in those countries where it is difficult to gain access to "classical" diagnostic tests.

Identifiants

pubmed: 31723835
doi: 10.1097/HS9.0000000000000208
pii: HemaSphere-2018-0197
pmc: PMC6746021
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e208

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK090554
Pays : United States

Informations de copyright

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.

Références

JAMA. 2014 Sep 10;312(10):1033-48
pubmed: 25203083
N Engl J Med. 2018 Apr 19;378(16):1479-1493
pubmed: 29669226
Orphanet J Rare Dis. 2010 May 21;5:11
pubmed: 20492708
Pharmaceuticals (Basel). 2018 Nov 21;11(4):
pubmed: 30469435
N Engl J Med. 2017 Apr 20;376(16):1561-1573
pubmed: 28423290
N Engl J Med. 2017 Mar 2;376(9):848-855
pubmed: 28249145
Blood Cells Mol Dis. 2018 Mar;69:82-89
pubmed: 29107441
Br J Haematol. 2011 Sep;154(6):736-44
pubmed: 21726207
Orphanet J Rare Dis. 2014 Jun 23;9:91
pubmed: 24957117
Blood. 2010 Jun 3;115(22):4331-6
pubmed: 20233970
Nat Rev Dis Primers. 2018 Mar 15;4:18010
pubmed: 29542687
Blood. 2016 Feb 18;127(7):810-9
pubmed: 26758919
Haematologica. 2014 May;99(5):811-20
pubmed: 24790059
Bull World Health Organ. 2001;79(8):704-12
pubmed: 11545326
Lancet. 2018 Jan 13;391(10116):155-167
pubmed: 28774421
Lancet. 2012 Dec 15;380(9859):2197-223
pubmed: 23245608
Blood. 2018 Apr 26;131(17):1960-1973
pubmed: 29519807
Science. 2014 Mar 28;343(6178):1520-2
pubmed: 24675962
Lancet. 2013 Jan 12;381(9861):142-51
pubmed: 23103089
Haematologica. 2015 Jan;100(1):3-6
pubmed: 25552677
Lancet Glob Health. 2014 Feb;2(2):e80-9
pubmed: 24748392
Haematologica. 2004 Mar;89(3):348-56
pubmed: 15020275
Semin Thromb Hemost. 2011 Apr;37(3):226-36
pubmed: 21455857
Blood Rev. 2018 Jul;32(4):300-311
pubmed: 29455932
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):361-370
pubmed: 30504333
ISBT Sci Ser. 2017 Feb;12(1):239-247
pubmed: 28484512
Biochim Biophys Acta. 2014 Oct;1842(10):1932-1941
pubmed: 24995601
Am J Prev Med. 2010 Apr;38(4 Suppl):S512-21
pubmed: 20331952
Blood. 2016 Apr 7;127(14):1814-22
pubmed: 26851292

Auteurs

Achille Iolascon (A)

Department of Molecular Medicine and Medical Biotechnology, University Federico II of Naples, Naples, Italy.

Lucia De Franceschi (L)

Department of Medicine University of Verona, AOUI Verona, Verona, Italy.

Martina Muckenthaler (M)

Department of Pediatric Hematology, Oncology and Immunology, University of Heidelberg, Heidelberg, Germany.

Ali Taher (A)

Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

David Rees (D)

Department of Paediatric Haematology, King's College Hospital, London, UK.

Mariane de Montalembert (M)

Department of Pediatrics, Necker-Enfants Malades Hospital, Paris, France.
Descartes University, Labex-GR-Ex, Paris, France.

Stefano Rivella (S)

Division of Hematology, Department of Pediatrics, The Children's Hospital of Philadelphia (CHOP), Philadelphia, PA, USA.

Androulla Eleftheriou (A)

Thalassaemia International Federation, Nicosia, Cyprus.

Maria Domenica Cappellini (MD)

Department of Clinical Sciences and Community, University of Milan, IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.

Classifications MeSH